ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 324979 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 324979; 2) Community: the network communities that were significantly associated with the response to NSC 324979; 3) Molecule: the relationships between components within communities and NSC 324979; 4) MDR: the compounds that were significantly associated with the NSC 324979.

NSC Compound Enrichment Correlation
NSC 683558 Camptothecin Derivative 0.0284045326811618 0.11536143
NSC 683864 Temsirolimus 0.0284045326811618 -0.006636714
NSC 735037 Camptothecin Derivative 0.0284045326811618 0.20402565
NSC 104801 Cytembena 0.0286383688883667 0.14344255
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.0286383688883668 0.49524272
NSC 615441 1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride 0.0286383688883668 0.47831882
NSC 626880 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-hydroxy- phenyl)methylene]-, hydrochloride 0.0286383688883668 0.43763582
NSC 632840 Null 0.0286383688883668 0.41197755
NSC 634472 Null 0.0286383688883668 0.3388119
NSC 637140 9-N-(N'-bis-chloroethyl-N-1,5-diaminopentyl)-2-methoxy acridine, dihydrochloride 0.0286383688883668 0.47961864
Total:104  Current:67    [First] [Prev] [Next] [Last]